Expect Less Concern Over Psychiatric Effects With Chantix

Boxed warnings about psychiatric events will be REMOVED from Chantix (varenicline) and bupropion labeling for smoking cessation.

These warnings about mood changes, agitation, nightmares, and other psychiatric risks were originally added based on case reports.

Now a large trial suggests that these meds do NOT increase psychiatric side effects in patients quitting smoking.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote